Personalis Stock
Personalis, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Christopher Hall
- Employees
- 260
- Market cap
- $1.7 B
- IPO
- 20/06/2019
Personalis, Inc. operates globally as a specialized cancer genomics firm within the Healthcare sector and the Medical - Diagnostics & Research industry. Founded in 2011 and headquartered in Fremont, the company provides advanced sequencing and data analysis capabilities designed to support the development of novel…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Personalis stock: price history
1D
-1.8%
1W
-2.2%
1M
-2.9%
6M
+132.5%
YTD
+96.6%
1Y
+52.2%
2Y
+227.4%
5Y
-21.5%
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~27% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Personalis
Analyst assessment of Personalis
PRICE TARGET LOW
US$9.00
CONSENSUS
US$14.95
MEDIAN
US$16.25
PRICE TARGET HIGH
US$17.00
0
STRONG BUY
8
BUY
4
HOLD
0
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 06/10/2026
Personalis stock metrics
P/E
-14.36
P/B
7.02
EV/EBITDA
-16.62
RETURN ON EQUITY
-13.5%
NET MARGIN
-141.7%
DEBT/EQUITY
0.16
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
67.4%
FLOAT SHARES
71,952,228
AVG. DAILY VOLUME (30D)
2,318,259
Insider transactions (SEC)
Hall Christopher M
Tachibana Aaron
Moore Stephen Michael
Chen Richard
Chen Richard
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.8%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Personalis stock
What does Personalis do?
Personalis, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Christopher Hall, the company employs around 260 people.
The IPO was on 20/06/2019; the stock trades on NASDAQ under the ticker PSNL.
What do analysts say about Personalis stock?
12 analysts rate the stock, the consensus is Buy (as of 06/10/2026).
The average price target is US$14.95, ranging from US$9.00 to US$17.00, with a median of US$16.25.
This is an external assessment, not a statement by Market Jury.
When does Personalis report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 27% stronger than usual.
Does Personalis pay a dividend?
No, Personalis currently does not pay a dividend.
Which stocks are comparable to Personalis?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Personalis stock analyzed?
Clicking "Analyze stock" lets five strategies assess Personalis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.